Wellnex Life (ASX:WNX) said it settled in full the deferred consideration for the Pain Away acquisition, resulting in annualized cost savings of around AU$600,000, according to a Friday filing with the Australian bourse.
It added that no further obligations to the Pain Away vendors remain.
A further disclosure will be issued at the beginning of trading on the AIM market of the London Stock Exchange on Friday.
Its shares fell over 5% on market close.